Are triglycerides the worst cholesterol?

Triglycerides aren't actually cholesterol but a different type of blood fat that can be just as harmful when elevated. While both high triglycerides and LDL cholesterol increase heart disease risk, triglycerides above 150 mg/dL are linked to pancreatitis, metabolic syndrome, and stroke.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding the Difference Between Triglycerides and Cholesterol

When you get your lipid panel results back, you'll see several numbers that all seem to relate to fat in your blood. But here's a crucial distinction many people miss: triglycerides aren't actually a type of cholesterol at all. They're a completely different type of blood lipid (fat) that serves a different purpose in your body.

Cholesterol is a waxy substance your body uses to build cell membranes, produce hormones, and create vitamin D. It travels through your bloodstream in packages called lipoproteins, which include LDL (low-density lipoprotein) and HDL (high-density lipoprotein). Triglycerides, on the other hand, are the most common type of fat in your body, storing excess energy from your diet.

Think of it this way: if cholesterol is like the building materials for your body's construction projects, triglycerides are like the fuel reserves in your tank. Both are necessary, but problems arise when you have too much of either circulating in your bloodstream.

Comparing Cardiovascular Risk Markers

MarkerOptimal LevelPrimary RiskResponse to Lifestyle
TriglyceridesTriglycerides<100 mg/dLPancreatitis, metabolic syndromeHighly responsive (20-50% reduction possible)
LDL-CLDL Cholesterol<100 mg/dLDirect plaque formationModerate response (10-20% reduction typical)
HDL-CHDL Cholesterol>40 mg/dL (M), >50 mg/dL (F)Low levels increase riskModest response (5-15% increase possible)
ApoBApolipoprotein B<90 mg/dLTotal atherogenic particlesModerate response (15-25% reduction)
TG/HDLTriglyceride/HDL Ratio<2.0Insulin resistance, small LDLHighly responsive to carb reduction

Different lipid markers provide unique insights into cardiovascular risk. Combining multiple markers gives the most complete picture.

Why High Triglycerides Are Dangerous

While triglycerides aren't cholesterol, elevated levels can be just as harmful to your cardiovascular health. Normal triglyceride levels should be below 150 mg/dL, with optimal levels under 100 mg/dL. When triglycerides climb above 150 mg/dL, they begin contributing to the hardening and thickening of artery walls (atherosclerosis), increasing your risk of heart attack and stroke.

The dangers escalate as levels rise. Triglycerides between 200-499 mg/dL are considered high, while levels above 500 mg/dL are very high and can trigger acute pancreatitis, a potentially life-threatening inflammation of the pancreas. At these extreme levels, the blood can actually appear milky due to the high fat content.

High triglycerides rarely travel alone. They're often part of a cluster of conditions known as metabolic syndrome, which includes high blood pressure, excess belly fat, high blood sugar, and abnormal cholesterol levels. This combination significantly multiplies your risk of heart disease, stroke, and type 2 diabetes. Understanding your complete lipid profile is essential for assessing your cardiovascular risk.

The Triglyceride-HDL Ratio: A Key Indicator

One of the most telling markers of metabolic health is your triglyceride-to-HDL cholesterol ratio. This ratio provides insight into your insulin sensitivity and the size of your LDL particles. A ratio above 3.5 suggests you likely have more small, dense LDL particles, which are more likely to burrow into artery walls and cause damage compared to larger, fluffier LDL particles.

Comparing Cardiovascular Risk: Triglycerides vs. LDL Cholesterol

So are triglycerides worse than LDL cholesterol? The answer isn't straightforward because both contribute to cardiovascular disease through different mechanisms. LDL cholesterol has long been considered the primary villain in heart disease, earning its 'bad cholesterol' nickname because it directly contributes to plaque buildup in arteries.

However, research increasingly shows that triglycerides are an independent risk factor for cardiovascular disease. A 2007 study in the Journal of the American Medical Association found that people with the highest triglyceride levels had twice the risk of heart disease compared to those with the lowest levels, even after accounting for other risk factors.

The most accurate picture of cardiovascular risk comes from looking at multiple markers together. While LDL cholesterol remains important, advanced markers like Apolipoprotein B (ApoB) provide even better risk assessment. ApoB measures the number of atherogenic particles in your blood, including those carrying triglycerides. Understanding how different lipid markers compare can help you and your healthcare provider make more informed decisions about your heart health.

The Role of Particle Size and Number

Recent research has shifted focus from just the amount of cholesterol to the number and size of particles carrying it. High triglycerides often correlate with a preponderance of small, dense LDL particles and lower HDL levels, creating a particularly atherogenic (artery-damaging) profile. This pattern, sometimes called the 'atherogenic lipid triad,' may be more predictive of heart disease than LDL cholesterol alone.

What Causes High Triglycerides?

Understanding what drives triglyceride levels up can help you take targeted action to lower them. Unlike cholesterol, which is significantly influenced by genetics, triglyceride levels are highly responsive to lifestyle factors.

Dietary Factors

The most significant dietary contributors to high triglycerides include:

  • Excess sugar and refined carbohydrates: Your liver converts excess carbs into triglycerides
  • Alcohol consumption: Even moderate drinking can significantly raise triglyceride levels in sensitive individuals
  • Trans fats and excessive saturated fats: Found in processed foods and fried items
  • Overall caloric excess: Consuming more calories than you burn, regardless of source

Medical Conditions and Medications

Several health conditions can elevate triglycerides:

  • Type 2 diabetes and prediabetes
  • Hypothyroidism
  • Kidney disease
  • Metabolic syndrome
  • Genetic conditions like familial hypertriglyceridemia

Certain medications can also raise triglyceride levels, including some diuretics, beta-blockers, steroids, and estrogen-containing medications.

Natural Ways to Lower Triglycerides

The good news is that triglycerides respond remarkably well to lifestyle changes, often more dramatically than cholesterol levels do. Many people can achieve significant reductions within weeks of making dietary and lifestyle modifications.

Dietary Strategies

  • Reduce sugar intake: Aim for less than 25g of added sugar daily
  • Choose complex carbohydrates: Replace refined grains with whole grains, vegetables, and legumes
  • Increase omega-3 fatty acids: Eat fatty fish twice weekly or consider supplementation
  • Limit alcohol: Even small amounts can significantly impact triglycerides in some people
  • Practice portion control: Weight loss of just 5-10% can reduce triglycerides by 20-30%

Exercise and Lifestyle Changes

Regular physical activity is one of the most effective ways to lower triglycerides. Aerobic exercise can reduce levels by 20-30%, with benefits seen even from moderate activity like brisk walking for 30 minutes daily. Resistance training also helps by improving insulin sensitivity and muscle mass.

Other lifestyle factors that impact triglycerides include getting adequate sleep (7-9 hours nightly), managing stress through techniques like meditation or yoga, and quitting smoking, which can improve triglyceride levels within weeks.

When to Consider Medical Treatment

While lifestyle changes should always be the first approach, some people need medication to manage dangerously high triglycerides. Medical treatment is typically considered when levels remain above 500 mg/dL despite lifestyle changes, or above 200 mg/dL with additional cardiovascular risk factors.

Common medications for high triglycerides include fibrates, omega-3 fatty acid supplements (prescription strength), niacin, and statins (which primarily lower cholesterol but can also reduce triglycerides). Your healthcare provider will consider your complete lipid profile, other health conditions, and cardiovascular risk factors when determining the best treatment approach. Regular monitoring through comprehensive lipid testing helps track your progress and adjust treatment as needed.

The Bottom Line: A Comprehensive Approach to Heart Health

While triglycerides aren't technically cholesterol, asking whether they're 'worse' misses the bigger picture. Both high triglycerides and elevated LDL cholesterol contribute to cardiovascular disease, often working together to damage your arteries. Rather than focusing on which is worse, the key is understanding and managing your complete lipid profile.

The most effective approach to heart health addresses all cardiovascular risk factors together. This means not just knowing your numbers but understanding what drives them and taking action to optimize each marker. Whether through dietary changes, increased physical activity, weight management, or medical treatment when necessary, you have significant power to improve your triglyceride levels and overall cardiovascular health.

Remember, cardiovascular disease develops over decades, but positive changes can begin immediately. Even modest improvements in triglyceride levels can significantly reduce your risk of heart disease and stroke, making the effort to understand and manage these important blood fats well worth your time.

References

  1. Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014;384(9943):626-635.[PubMed][DOI]
  2. Miller M, Stone NJ, Ballantyne C, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123(20):2292-2333.[PubMed][DOI]
  3. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007;298(3):309-316.[PubMed][DOI]
  4. Berglund L, Brunzell JD, Goldberg AC, et al. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(9):2969-2989.[PubMed][DOI]
  5. Boekholdt SM, Arsenault BJ, Mora S, et al. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. JAMA. 2012;307(12):1302-1309.[PubMed][DOI]
  6. Jacobson TA, Ito MK, Maki KC, et al. National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary. J Clin Lipidol. 2014;8(5):473-488.[PubMed][DOI]

Frequently Asked Questions

How can I test my triglycerides at home?

You can test your triglycerides at home with SiPhox Health's Apob Advanced Cholesterol Panel, which includes triglycerides along with other essential lipid markers. For ongoing monitoring, the Heart & Metabolic Program includes triglyceride testing with personalized insights to help you track and improve your levels over time.

What is the normal range for triglycerides?

Normal triglyceride levels are below 150 mg/dL, with optimal levels under 100 mg/dL. Levels between 150-199 mg/dL are borderline high, 200-499 mg/dL are high, and above 500 mg/dL are very high and require immediate medical attention due to pancreatitis risk.

How quickly can I lower my triglycerides?

Triglycerides can respond quickly to lifestyle changes. Many people see significant reductions within 2-4 weeks of dietary modifications, especially by cutting sugar and refined carbohydrates. Adding regular exercise and losing even 5-10% of body weight can reduce levels by 20-30% within a few months.

Can triglycerides be high even if my cholesterol is normal?

Yes, it's possible to have high triglycerides with normal cholesterol levels. This pattern is often seen in people with insulin resistance, metabolic syndrome, or those who consume excessive sugar and refined carbohydrates. That's why comprehensive lipid testing that includes both cholesterol and triglycerides is important.

What foods raise triglycerides the most?

Foods that spike triglycerides include sugary drinks, candy, baked goods with refined flour, alcohol, and foods high in saturated fats. Surprisingly, even healthy foods like fruit juice and honey can raise triglycerides when consumed in excess due to their high fructose content.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details